Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
about
Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel DiseaseTolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel diseaseSelective cyclooxygenase 2 inhibitors for the treatment of rheumatological manifestations of inflammatory bowel diseasePreventive health measures in inflammatory bowel diseaseDrug-induced side effects affecting the gastrointestinal tractEnvironmental risk factors for inflammatory bowel diseases: Evidence based literature reviewThe functional -765G→C polymorphism of the COX-2 gene may reduce the risk of developing crohn's diseaseRole of selective cyclooxygenase-2 inhibitors in exacerbation of inflammatory bowel disease: A systematic review and meta-analysisNonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease.5-Aminosalicylic acid, a specific drug for ulcerative colitis.Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease.Mucosal inflammation in spondylarthritides: past, present, and future.Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study.Rheumatological manifestations in inflammatory bowel disease.
P2860
Q22241416-18D475A8-4D07-4846-AAEB-150E9DB4D0A9Q24193086-631165FE-1ADC-4E8A-88D8-BBCB1678AEBAQ24240479-BDAF38E7-1059-4B36-9BD1-2FCD174F7719Q28078112-630C9756-085D-49DF-B159-79CD6B257F75Q28219073-74445C34-187C-4E0B-B01E-EAD698E0ED46Q30248747-5A9F30F4-0F6E-4C16-8DC0-89C2D27C8CE4Q33760727-A922ECBE-EC5A-4090-8BD9-DC128B6926CAQ35137854-352E25DA-4DEA-470E-AD70-A0403141419AQ38260150-C2EEB709-A77F-4026-98FF-3336616B7FA7Q38367034-22425383-A0DE-43FA-BD43-73C82E28C283Q38974245-88E6153C-B81E-4A49-9B0F-E54E25FC9CD7Q39730329-0A48AAE1-0A00-4FEB-97F7-8E61C61CE565Q41610897-0EB4A644-9EAE-4A40-894B-D2A87A90EF5EQ42406810-DEE68DCC-37BC-4996-A5FA-5F0DB3683275
P2860
Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
@en
Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
@nl
type
label
Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
@en
Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
@nl
prefLabel
Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
@en
Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
@nl
P2093
P2860
P1476
Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
@en
P2093
Biancone L
Emerenziani S
Petruzziello C
P2860
P304
P356
10.1111/J.1365-2036.2004.01907.X
P407
P577
2004-04-01T00:00:00Z